
About Candle Pharmaceuticals LLP
Data last updated:
Candle Pharmaceuticals LLP is a limited liability partnership (LLP) based in Chandigarh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 March 2018 and has been in existence for over 8 years.
The LLP is registered with the Registrar of Companies (ROC), Chandigarh, under LLPIN AAM-1584. Its GSTIN is 04AANFC2741B1ZZ (Chandigarh).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Sachin Dhingra and Suhail Singh Puri.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at SCO 909 First Floor Nac Manimajra, Chandigarh, India – 160101.
As per the financials filed for FY 2019, the LLP reported a revenue of ₹4.4 Lakh. For the same year it recorded a net loss of ₹1.36 Lakh (net margin -31%) and EBITDA of ₹4.4 Lakh (EBITDA margin 100.1%).
Court records list 3 cases involving the LLP, including 1 filed by the LLP and 2 filed against it; 1 case is pending.
For more details, the LLP can be reached via its website candlepharma.com.
Company details
Contact details
Candle Pharmaceuticals LLP's registered office is in Chandigarh, Chandigarh. Its website is candlepharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressSCO 909 First Floor Nac Manimajra, Chandigarh, India – 160101
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Candle Pharmaceuticals LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Candle Pharmaceuticals LLP
FY 2025 filings availableCandle Pharmaceuticals LLP reported revenue of ₹4.4 Lakh for FY 2019.
Financial Statement Summary
| Statement of Account and Solvency | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Income and Expenditure | ||
| Turnover | ₹4.4 Lakh | |
| Other Income | ||
| Total Income | ||
| Purchases and Direct Costs | ||
| Personnel Expenses | ||
| Administrative Expenses | ||
| Interest | ||
| Depreciation | ||
| Total Expenses | ||
| Profit Before Tax | ||
| Tax | ||
| Profit After Tax | -₹1.36 Lakh | |
| Profit Transferred to Partners | ||
| Assets and Liabilities | ||
| Partners' Contribution | ||
| Reserves and Surplus | ||
| Secured Loans | ||
| Unsecured Loans | ||
| Trade Payables | ||
| Other Liabilities and Provisions | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Loans and Advances | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Statement of Account and Solvency | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profitability | ||
| Net Profit Margin | -31% | |
| Return on Partners' Funds | ||
| Return on Assets | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Debt to Partners' Funds | ||
| Interest Coverage | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Turnover Growth | ||
| Profit Growth | ||
To see the full financial statements and ratios of Candle Pharmaceuticals LLP, buy the company report.
Designated partners of Candle Pharmaceuticals LLP
Candle Pharmaceuticals has 2 current designated partners and 3 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sachin Dhingra Also directs: Apexderma Private Limited | Designated Partner | 05 Mar 2018 | 8 Years 8 Months | Current |
| Suhail Singh Puri Also directs: Remedical Lifesciences Private Limited | Designated Partner | 22 Sep 2025 | 1 Years 1 Months | Current |
Legal cases
Candle Pharmaceuticals LLP has 3 court cases on record: 1 filed by Candle Pharmaceuticals, 2 filed against it. 1 case is pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 2 | 1 |
Cases on record (2 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by M/S Zoic Biotech Private Limited | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against an individual | Pending |
To see the full case history of Candle Pharmaceuticals LLP, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Candle Pharmaceuticals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Candle Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AANFC2741B1ZZ | Chandigarh | Active | 03 May 2018 |
To see the full GST registrations and return filing status of Candle Pharmaceuticals LLP, buy the company report.
Recent activity
Candle Pharmaceuticals LLP has 5 designated partner changes on record since 2018: 4 appointments and 1 cessation. The latest: Suhail Singh Puri was appointed as Designated Partner on 22 Sep 2025.
Frequently asked questions
Candle Pharmaceuticals is an active limited liability partnership based in Chandigarh, India. The LLP works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 March 2018 (8+ years old) and is registered under LLPIN AAM-1584.
Candle Pharmaceuticals has 2 current designated partners:
- Sachin Dhingra - Designated Partner
- Suhail Singh Puri - Designated Partner
The latest financial statements of Candle Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Candle Pharmaceuticals is 04AANFC2741B1ZZ, registered in Chandigarh.
The LLPIN (Limited Liability Partnership Identification Number) of Candle Pharmaceuticals is AAM-1584. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Candle Pharmaceuticals has 3 court cases on record: 1 filed by the LLP and 2 filed against it. 1 is pending.
Candle Pharmaceuticals was incorporated on 05 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chandigarh.
Suhail Singh Puri was appointed as Designated Partner on 22 Sep 2025. Kapil Madan was appointed as Designated Partner on 31 Mar 2023. Lohit Bindra was appointed as Designated Partner on 19 Nov 2019. Candle Pharmaceuticals has 5 designated partner changes on record in total.
Candle Pharmaceuticals can be reached through the website candlepharma.com. Its registered office is in Chandigarh, India.
The registered office of Candle Pharmaceuticals is at SCO 909 First Floor Nac Manimajra, Chandigarh, India – 160101.

